OnKure will now hold its investor call to review preliminary data from the PIKture-01 study of OKI-219 on Tuesday, December 10, 2024 at 7:00 a.m. CT (8:00 a.m. ET). The Company had previously ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

In early 20th-century Cleveland, smokestacks from steel mills cast long shadows across the city, draping it in a gray haze.

The tour was hosted by Madame Architect, a media platform dedicated to advancing the work of women in the design industry.

A number of exhibitors at the recent EuroTier Show in Germany say they are concerned about ‘Chinese corporate spying’ at the ...

(NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment ... in Fed and ...

Prof. Robert Sutton to deliver plenary presentation on Phase 2b CARPO trial of AuxoraTM in Acute Pancreatitis (AP) at ...

The three-day Carbon Fiber Conference, held in Charleston, S.C., addressed a variety of carbon fiber/composites related ...

Records show that Winfrey's Harpo Productions was paid following her star-studded town hall event for the Democrat — but ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers ...

An oral presentation at the Michael J. Fox Foundation’s 16 th Annual Parkinson’s Disease Therapeutics Conference in October 2024 in New York, NY. A virtual webinar hosted by Gain Therapeutics in ...

New in vitro preclinical data show CLN-978 induced similar T cell activation, target B cell depletion, and cytokine production in human peripheral blood mononuclear cells (PBMC) derived from patients ...